+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatology CRO Market Size, Share & Trends Analysis Report By Type (Preclinical, Clinical, Drug Discovery), By Service (Clinical Monitoring, Regulatory/Medical Affairs), By Region, and Segment Forecasts, 2021-2028

  • PDF Icon

    Report

  • 120 Pages
  • October 2021
  • Region: Global
  • Grand View Research
  • ID: 5457617
The global dermatology CRO market size is expected to reach USD 7.04 billion by 2028. It is expected to expand at a CAGR of 6.9% from 2021 to 2028. The rise in demand for topical dermatological medications, such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients, to treat acne is a major factor driving the market. Furthermore, increased awareness regarding skin diseases, high demand for speedy diagnosis, and an increase in the prevalence of skin cancer and other skin problems are all driving the industry forward.





The COVID-19 pandemic shook the economy in 2020 and has an ongoing impact on various industries across the globe. The market for dermatology contract research organizations (CRO) was largely unaffected by the repercussions of the pandemic owing to the emergence of virtual clinical trials and government initiatives to sustain the disrupted supply chains in healthcare. Moreover, with the ongoing vaccination drives and lifting of shelter in place mandates, the bottlenecking of clinical trials is improving. Thus, the future seems good for the market.

Factors such as increased investment in R&D programs, a preference for outsourcing tasks due to time and cost constraints, and patent expiration in the dermatology industry are some of the key factors expected to drive the market over the forecast period. Contract research outsourcing collaborations provide cutting-edge services, thus pharmaceutical players and government agencies prefer to delegate projects to dermatology CROs, allowing the market to develop.

Dermatology CRO Market Report Highlights

  • Based on type, the clinical segment grabbed the largest revenue share of over 75.0% in 2020 owing to technological advancements, globalization of clinical trials, and the need for dermatology CROs to conduct clinical trials.
  • In the clinical type segment, the phase III segment accounted for the largest revenue share of over 50.0% in 2020 as phase III clinical trials are the most expensive and involve a large patient pool.
  • By service, clinical monitoring held the largest revenue share in 2020 owing to an increase in the number of clinical trials and the need to monitor those trials efficiently.
  • Asia Pacific captured the largest revenue share of over 40.0% in 2020. This is due to the high prevalence of skin disorders, diversity in populations, the ease with which patients may be recruited and retained, and improving regulatory framework.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Dermatology CRO Market

What is the estimated value of the Global Dermatology CRO Market?

The Global Dermatology CRO Market was estimated to be valued at $4.43 billion in 2021.

What is the growth rate of the Global Dermatology CRO Market?

The growth rate of the Global Dermatology CRO Market is 6.8%, with an estimated value of $7.04 billion by 2028.

What is the forecasted size of the Global Dermatology CRO Market?

The Global Dermatology CRO Market is estimated to be worth $7.04 billion by 2028.

Who are the key companies in the Global Dermatology CRO Market?

Key companies in the Global Dermatology CRO Market include IQVIA, Covance, Inc., Pharmaceutical Product development, Inc., Parexel International Corporation, Charles River Laboratories International, Inc., Icon, Plc, Syneos Health, Wuxi Apptec and Proinnovera.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Dermatology CRO Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Dermatology CRO: Market Analysis Tools
3.4.1. Industry analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat from new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL analysis
3.4.2.1. Political landscape
3.4.2.2. Environmental landscape
3.4.2.3. Social landscape
3.4.2.4. Technology landscape
3.4.2.5. Legal landscape
Chapter 4. Dermatology CRO Market: Segment Analysis, by Type, 2016 - 2028 (USD Million)
4.1. Dermatology CRO Market: Type Movement Analysis
4.2. Drug Discovery
4.2.1. Drug discovery market, 2016 - 2028 (USD Million)
4.2.1.1. Target Validation
4.2.1.1.1. Target validation market, 2016 - 2028 (USD Million)
4.2.1.2. Lead Identification
4.2.1.2.1. Lead identification market, 2016 - 2028 (USD Million)
4.2.1.3. Lead optimization
4.2.1.3.1. Lead optimization market, 2016 - 2028 (USD Million)
4.3. Preclinical
4.3.1. Preclinical market, 2016 - 2028 (USD Million)
4.4. Clinical
4.4.1. Clinical market, 2016 - 2028 (USD Million)
4.4.1.1. Phase I
4.4.1.1.1. Phase I market, 2016 - 2028 (USD Million)
4.4.1.2. Phase II
4.4.1.2.1. Phase II market, 2016 - 2028 (USD Million)
4.4.1.3. Phase III
4.4.1.3.1. Phase III market, 2016 - 2028 (USD Million)
4.4.1.4. Phase IV
4.4.1.4.1. Phase IV market, 2016 - 2028 (USD Million)
Chapter 5. Dermatology CRO Market: Segment Analysis, by Service, 2016 - 2028 (USD Million)
5.1. Dermatology CRO Market: Service Movement Analysis
5.2. Project Management/Clinical Supply Management
5.2.1. Project management/clinical supply management market, 2016 - 2028 (USD Million)
5.3. Data Management
5.3.1. Data management market, 2016 - 2028 (USD Million)
5.4. Regulatory/Medical Affairs
5.4.1. Regulatory/medical affairs market, 2016 - 2028 (USD Million)
5.5. Medical Writing
5.5.1. Medical writing market, 2016 - 2028 (USD Million)
5.6. Clinical Monitoring
5.6.1. Clinical monitoring market, 2016 - 2028 (USD Million)
5.7. Quality Management/ Assurance
5.7.1. Quality management/ assurance market, 2016 - 2028 (USD Million)
5.8. Bio-statistics
5.8.1. Bio-statistics market, 2016 - 2028 (USD Million)
5.9. Investigator Payments
5.9.1. Investigator payments market, 2016 - 2028 (USD Million)
5.10. Laboratory
5.10.1. Laboratory market, 2016 - 2028 (USD Million)
5.11. Patient and Site Recruitment
5.11.1. Patient & site recruitment market, 2016 - 2028 (USD Million)
5.12. Technology
5.12.1. Technology market, 2016 - 2028 (USD Million)
5.13. Others
5.13.1. Others market, 2016 - 2028 (USD Million)
Chapter 6. Dermatology CRO Market: Regional Market Analysis, 2016 - 2028 (USD Million)
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2020 & 2028
6.3. North America
6.3.1. North America market estimates and forecast, 2016 - 2028 (USD Million)
6.3.2. U.S.
6.3.2.1. U.S. market estimates and forecast, 2016 - 2028 (USD Million)
6.3.3. Canada
6.3.3.1. Canada market estimates and forecast, 2016 - 2028 (USD Million)
6.4. Europe
6.4.1. Europe market estimates and forecast, 2016 - 2028 (USD Million)
6.4.2. U.K.
6.4.2.1. U.K. market estimates and forecast, 2016 - 2028 (USD Million)
6.4.3. Germany
6.4.3.1. Germany market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.4. France
6.4.4.1. France market estimates and forecast, 2016 - 2028 (USD Million)
6.4.5. Italy
6.4.5.1. Italy market estimates and forecasts, 2016 - 2028 (USD Million)
6.4.6. Spain
6.4.6.1. Spain market estimates and forecast, 2016 - 2028 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
6.5.2. India
6.5.2.1. India market estimates and forecast, 2016 - 2028 (USD Million)
6.5.3. Japan
6.5.3.1. Japan market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.4. China
6.5.4.1. China market estimates and forecast, 2016 - 2028 (USD Million)
6.5.5. Australia
6.5.5.1. Australia market estimates and forecasts, 2016 - 2028 (USD Million)
6.5.6. South Korea
6.5.6.1. South Korea market estimates and forecast, 2016 - 2028 (USD Million)
6.6. Latin America
6.6.1. Latin America market estimates and forecast, 2016 - 2028 (USD Million)
6.6.2. Brazil
6.6.2.1. Brazil market estimates and forecast, 2016 - 2028 (USD Million)
6.6.3. Mexico
6.6.3.1. Mexico market estimates and forecasts, 2016 - 2028 (USD Million)
6.6.4. Argentina
6.6.4.1. Argentina market estimates and forecast, 2016 - 2028 (USD Million)
6.6.5. Colombia
6.6.5.1. Colombia market estimates and forecasts, 2016 - 2028 (USD Million)
6.6.6. Chile
6.6.6.1. Chile market estimates and forecast, 2016 - 2028 (USD Million)
6.7. MEA
6.7.1. MEA market estimates and forecast, 2016 - 2028 (USD Million)
6.7.2. South Africa
6.7.2.1. South Africa market estimates and forecast, 2016 - 2028 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Saudi Arabia market estimates and forecasts, 2016 - 2028 (USD Million)
6.7.4. UAE
6.7.4.1. UAE market estimates and forecast, 2016 - 2028 (USD Million)
6.7.5. Iran
6.7.5.1. Iran market estimates and forecasts, 2016 - 2028 (USD Million)
6.7.6. Israel
6.7.6.1. Israel market estimates and forecast, 2016 - 2028 (USD Million)
Chapter 7. Dermatology CRO Market - Competitive Analysis
7.1. Key Company Profiles
7.1.1. IQVIA
7.1.1.1. Company overview
7.1.1.2. Financial performance
7.1.1.3. Product benchmarking
7.1.1.4. Strategic initiatives
7.1.2. Covance, Inc.
7.1.2.1. Company overview
7.1.2.2. Financial performance
7.1.2.3. Product benchmarking
7.1.2.4. Strategic initiatives
7.1.3. Pharmaceutical Product development, Inc.
7.1.3.1. Company overview
7.1.3.2. Financial performance
7.1.3.3. Product benchmarking
7.1.3.4. Strategic initiatives
7.1.4. Parexel International Corporation
7.1.4.1. Company overview
7.1.4.2. Financial performance
7.1.4.3. Product benchmarking
7.1.4.4. Strategic initiatives
7.1.5. Charles River Laboratories International, Inc.
7.1.5.1. Company overview
7.1.5.2. Financial performance
7.1.5.3. Product benchmarking
7.1.5.4. Strategic initiatives
7.1.6. Icon, Plc
7.1.6.1. Company overview
7.1.6.2. Financial performance
7.1.6.3. Product benchmarking
7.1.6.4. Strategic initiatives
7.1.7. Syneos Health
7.1.7.1. Company overview
7.1.7.2. Financial performance
7.1.7.3. Product benchmarking
7.1.7.4. Strategic initiatives
7.1.8. Wuxi Apptec
7.1.8.1. Company overview
7.1.8.2. Financial performance
7.1.8.3. Product benchmarking
7.1.8.4. Strategic initiatives
7.1.9. Bioskin
7.1.9.1. Company overview
7.1.9.2. Financial performance
7.1.9.3. Product benchmarking
7.1.9.4. Strategic initiatives
7.1.10. Proinnovera
7.1.10.1. Company overview
7.1.10.2. Financial performance
7.1.10.3. Product benchmarking
7.1.10.4. Strategic initiatives
List of Tables
Table 1 Global Dermatology CRO Market, by Region, 2016-2028 (USD Million)
Table 2 Global Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 3 Global Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 4 Global Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 5 Global Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 6 North America Dermatology CRO Market, by Country, 2016-2028 (USD Million)
Table 7 North America Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 8 North America Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 9 North America Dermatology CRO Market, by Clinical Trials, 2016-2028 (SD Million)
Table 10 North America Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 11 U.S. Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 12 U.S. Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 13 U.S. Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 14 U.S. Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 15 Canada Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 16 Canada Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 17 Canada Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 18 Canada Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 19 Europe Dermatology CRO Market, by Region, 2016-2028 (USD Million)
Table 20 Europe Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 21 Europe Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 22 Europe Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 23 Europe Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 24 U.K. Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 25 U.K. Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 26 U.K. Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 27 U.K. Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 28 Germany Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 29 Germany Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 30 Germany Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 31 Germany Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 32 France Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 33 France Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 34 France Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 35 France Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 36 Italy Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 37 Italy Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 38 Italy Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 39 Italy Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 40 Spain Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 41 Spain Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 42 Spain Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 43 Spain Dermatology CRO Market, by Service, 2016-2028 (USD Million
Table 44 Asia Pacific Dermatology CRO Market, by Region, 2016-2028 (USD Million)
Table 45 Asia Pacific Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 46 Asia Pacific Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 47 Asia Pacific Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 48 Asia Pacific Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 49 India Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 50 India Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 51 India Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 52 India Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 53 Japan Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 54 Japan Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 55 Japan Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 56 Japan Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 57 China Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 58 China Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 59 China Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 60 China Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 61 Australia Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 62 Australia Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 63 Australia Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 64 Australia Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 65 South Korea Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 66 South Korea Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 67 South Korea Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 68 South Korea Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 69 Latin America Dermatology CRO Market, by Region, 2016-2028 (USD Million)
Table 70 Latin America Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 71 Latin America Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 72 Latin America Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 73 Latin America Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 74 Brazil Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 75 Brazil Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 76 Brazil Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 77 Brazil Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 78 Mexico Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 79 Mexico Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 80 Mexico Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 81 Mexico Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 82 Argentina Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 83 Argentina Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 84 Argentina Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 85 Argentina Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 86 Colombia Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 87 Colombia Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 88 Colombia Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 89 Colombia Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 90 Chile Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 91 Chile Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 92 Chile Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 93 Chile Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 94 MEA Dermatology CRO Market, by Region, 2016-2028 (USD Million)
Table 95 MEA Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 96 MEA Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 97 MEA Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 98 MEA Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 99 South Africa Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 100 South Africa Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 101 South Africa Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 102 South Africa Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 103 Saudi Arabia Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 104 Saudi Arabia Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 105 Saudi Arabia Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 106 Saudi Arabia Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 107 UAE Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 108 UAE Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 109 UAE Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 110 UAE Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 111 Iran Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 112 Iran Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 113 Iran Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 114 Iran Dermatology CRO Market, by Service, 2016-2028 (USD Million)
Table 115 Israel Dermatology CRO Market, by Type, 2016-2028 (USD Million)
Table 116 Israel Dermatology CRO Market, by Drug Discovery, 2016-2028 (USD Million)
Table 117 Israel Dermatology CRO Market, by Clinical Trials, 2016-2028 (USD Million)
Table 118 Israel Dermatology CRO Market, by Service, 2016-2028 (USD Million)
List of Figures
FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market segmentation & scope
FIG. 8 Dermatology CRO market outlook, 2016-2028
FIG. 9 Market trends & outlook
FIG. 10 Penetration & growth prospect mapping by service, 2020
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 16 Global Dermatology CRO market: Type movement analysis
FIG. 17 Global Dermatology CRO market: Service movement analysis
FIG. 18 Regional market place: Key takeaway
FIG. 19 Dermatology CRO regional outlook, 2020 & 2028
FIG. 20 North America Dermatology CRO market, 2016-2028 (USD Million)
FIG. 21 U.S. Dermatology CRO market, 2016-2028 (USD Million)
FIG. 22 Canada Dermatology CRO market, 2016-2028 (USD Million)
FIG. 23 Europe Dermatology CRO market, 2016-2028 (USD Million)
FIG. 24 Germany Dermatology CRO market, 2016-2028 (USD Million)
FIG. 25 France Dermatology CRO market, 2016-2028 (USD Million)
FIG. 26 U.K. Dermatology CRO market, 2016-2028 (USD Million)
FIG. 27 Spain Dermatology CRO market, 2016-2028 (USD Million)
FIG. 28 Italy Dermatology CRO market, 2016-2028 (USD Million)
FIG. 29 Asia Pacific Dermatology CRO market, 2016-2028 (USD Million)
FIG. 30 China Dermatology CRO market, 2016-2028 (USD Million)
FIG. 31 Japan Dermatology CRO market, 2016-2028 (USD Million)
FIG. 32 India Dermatology CRO market, 2016-2028 (USD Million)
FIG. 33 Australia Dermatology CRO market, 2016-2028 (USD Million)
FIG. 34 South Korea Dermatology CRO market, 2016-2028 (USD Million)
FIG. 35 Latin America Dermatology CRO market, 2016-2028 (USD Million)
FIG. 36 Brazil Dermatology CRO market, 2016-2028 (USD Million)
FIG. 37 Mexico Dermatology CRO market, 2016-2028 (USD Million)
FIG. 38 Argentina Dermatology CRO market, 2016-2028 (USD Million)
FIG. 39 Colombia Dermatology CRO market, 2016-2028 (USD Million)
FIG. 40 Chile Dermatology CRO market, 2016-2028 (USD Million)
FIG. 41 Middle East & Africa Dermatology CRO market, 2016-2028 (USD Million)
FIG. 42 South Africa Dermatology CRO market, 2016-2028 (USD Million)
FIG. 43 Saudi Arabia Dermatology CRO market, 2016-2028 (USD Million)
FIG. 44 UAE Dermatology CRO market, 2016-2028 (USD Million)
FIG. 45 Colombia Arabia Dermatology CRO market, 2016-2028 (USD Million)
FIG. 46 Chile Dermatology CRO market, 2016-2028 (USD Million)

Companies Mentioned

  • IQVIA
  • Covance, Inc.
  • Pharmaceutical Product development, Inc.
  • Parexel International Corporation
  • Charles River Laboratories International, Inc.
  • Icon, Plc
  • Syneos Health
  • Wuxi Apptec
  • Bioskin
  • Proinnovera

Methodology

Loading
LOADING...